US6743777B1
(en)
*
|
1992-03-19 |
2004-06-01 |
Eli Lilly And Company |
Cyclic peptide antifungal agents and process for preparation thereof
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US7208011B2
(en)
*
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US6423345B2
(en)
*
|
1998-04-30 |
2002-07-23 |
Acusphere, Inc. |
Matrices formed of polymer and hydrophobic compounds for use in drug delivery
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
ATE428371T1
(de)
*
|
1998-07-17 |
2009-05-15 |
Pacira Pharmaceuticals Inc |
Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
|
WO2000051564A1
(en)
*
|
1999-03-03 |
2000-09-08 |
Eli Lilly And Company |
Echinocandin pharmaceutical formulations containing micelle-forming surfactants
|
EP1157030B1
(de)
|
1999-03-03 |
2003-08-27 |
Eli Lilly And Company |
Echinocandin-kohlenhydrate-komplexe
|
EP1642572A1
(de)
*
|
1999-05-27 |
2006-04-05 |
Acusphere, Inc. |
Poröse Matrices für Arzneistoffe und deren Herstellungsverfahren
|
US7919119B2
(en)
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
CN100376291C
(zh)
*
|
1999-05-27 |
2008-03-26 |
阿库斯菲尔公司 |
多孔药物基质及其制造方法
|
JP4722295B2
(ja)
*
|
1999-05-27 |
2011-07-13 |
エイカスフィアー・インコーポレーテッド |
多孔性薬剤マトリクスおよびその製造方法
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
JP2003520210A
(ja)
*
|
2000-01-05 |
2003-07-02 |
イマレックス セラピューティクス, インコーポレイテッド |
低い水溶性を有する薬物の送達のための薬学的処方物
|
US6589557B2
(en)
*
|
2000-06-15 |
2003-07-08 |
Acusphere, Inc. |
Porous celecoxib matrices and methods of manufacture thereof
|
EP1582180B1
(de)
|
2000-10-16 |
2008-02-27 |
Conor Medsystems, Inc. |
Expandierbare medizinische Vorrichtung zum Zuführen eines Heilmittels
|
WO2002032398A2
(en)
*
|
2000-10-16 |
2002-04-25 |
Massachusetts Institute Of Technology |
Lipid-protein-sugar particles for drug delivery
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
CA2450957A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Pfizer Products Inc. |
Pharmaceutical compositions of dispersions of drugs and neutral polymers
|
US7842083B2
(en)
|
2001-08-20 |
2010-11-30 |
Innovational Holdings, Llc. |
Expandable medical device with improved spatial distribution
|
US7056338B2
(en)
*
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
WO2003035051A2
(en)
*
|
2001-10-19 |
2003-05-01 |
Inhale Therapeutic Systems, Inc. |
The use of proton sequestering agents in drug formulations
|
US9308220B2
(en)
|
2001-12-11 |
2016-04-12 |
Cosmo Technologies Limited |
Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
|
ITMI20012599A1
(it)
*
|
2001-12-11 |
2003-06-11 |
Cosmo Spa |
Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
|
AU2003221497A1
(en)
|
2002-03-13 |
2003-09-22 |
Novartis Ag |
Pharmaceutical microparticles
|
US20040009231A1
(en)
*
|
2002-03-20 |
2004-01-15 |
Advanced Inhalation Research, Inc. |
hGH (human growth hormone) formulations for pulmonary administration
|
US7008644B2
(en)
*
|
2002-03-20 |
2006-03-07 |
Advanced Inhalation Research, Inc. |
Method and apparatus for producing dry particles
|
US6991800B2
(en)
*
|
2002-06-13 |
2006-01-31 |
Vicuron Pharmaceuticals Inc. |
Antifungal parenteral products
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
AU2003279070A1
(en)
*
|
2002-09-30 |
2004-04-23 |
Acusphere Inc |
Sustained release porous microparticles for inhalation
|
EP1575638A1
(de)
*
|
2002-11-08 |
2005-09-21 |
Conor Medsystems, Inc. |
Expandierbare medizinische vorrichtung und verfahren, um chronische totalverschlüsse mittels lokaler zuführung von angiogenesefaktoren zu behandeln
|
GB0228571D0
(en)
*
|
2002-12-06 |
2003-01-15 |
Novartis Ag |
Organic compounds
|
US6962006B2
(en)
*
|
2002-12-19 |
2005-11-08 |
Acusphere, Inc. |
Methods and apparatus for making particles using spray dryer and in-line jet mill
|
US20040121003A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
US20040202692A1
(en)
*
|
2003-03-28 |
2004-10-14 |
Conor Medsystems, Inc. |
Implantable medical device and method for in situ selective modulation of agent delivery
|
WO2004087214A1
(en)
|
2003-03-28 |
2004-10-14 |
Conor Medsystems, Inc. |
Implantable medical device with beneficial agent concentration gradient
|
JP5064794B2
(ja)
*
|
2003-03-31 |
2012-10-31 |
タイタン ファーマシューティカルズ インコーポレイテッド |
ドパミンアゴニストの徐放のための移植可能なポリマーデバイス
|
US20040247624A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US7785512B1
(en)
|
2003-07-31 |
2010-08-31 |
Advanced Cardiovascular Systems, Inc. |
Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
|
US7645474B1
(en)
*
|
2003-07-31 |
2010-01-12 |
Advanced Cardiovascular Systems, Inc. |
Method and system of purifying polymers for use with implantable medical devices
|
WO2005025545A2
(en)
*
|
2003-09-17 |
2005-03-24 |
Aderis Pharmaceuticals, Inc. |
Pharmaceutical formulation for controlled release of selodenoson
|
US20050069591A1
(en)
*
|
2003-09-30 |
2005-03-31 |
Howard Bernstein |
Injectable, oral, or topical sustained release pharmaceutical formulations
|
JP4235226B2
(ja)
*
|
2003-10-10 |
2009-03-11 |
サムヤン コーポレイション |
両親媒性ブロック共重合体及びそれを含む薬剤送達用高分子組成物
|
US20050084455A1
(en)
*
|
2003-10-16 |
2005-04-21 |
Council Of Scientific & Industrial Research |
Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof
|
US8157788B2
(en)
*
|
2003-11-06 |
2012-04-17 |
Paolo L. Manfredi |
Multi-site drug delivery platform
|
US20050100577A1
(en)
*
|
2003-11-10 |
2005-05-12 |
Parker Theodore L. |
Expandable medical device with beneficial agent matrix formed by a multi solvent system
|
CA2547774A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Method for making pharmaceutical multiparticulates
|
JP2007513147A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
EP1694304A2
(de)
*
|
2003-12-04 |
2006-08-30 |
Pfizer Products Inc. |
Multiteilchenförmige dosierformen von azithromycin durch verfahren auf flüssigkeitsbasis
|
CA2547597A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate compositions with improved stability
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
KR20050104152A
(ko)
|
2004-04-28 |
2005-11-02 |
최승호 |
경구용 약물의 흡수를 증진하는 약제학적 조성물
|
US7446131B1
(en)
|
2004-06-10 |
2008-11-04 |
The United States Of America As Represented By The Secretary Of Agriculture |
Porous polymeric matrices made of natural polymers and synthetic polymers and optionally at least one cation and methods of making
|
WO2006012502A2
(en)
*
|
2004-07-23 |
2006-02-02 |
Rigel Pharmaceuticals, Inc. |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
US7862835B2
(en)
*
|
2004-10-27 |
2011-01-04 |
Boston Scientific Scimed, Inc. |
Method of manufacturing a medical device having a porous coating thereon
|
US8128952B2
(en)
*
|
2005-01-12 |
2012-03-06 |
Clemson University Research Foundation |
Ligand-mediated controlled drug delivery
|
DE102005002703C5
(de)
*
|
2005-01-19 |
2013-07-04 |
Heraeus Kulzer Gmbh |
Antibiotische Beschichtung von Implantaten sowie Verfahren zur antibiotischen Beschichtung
|
WO2006099514A2
(en)
*
|
2005-03-14 |
2006-09-21 |
Biotegra, Inc. |
Drug delivery compositions and related methods
|
CA2631875A1
(en)
*
|
2005-12-06 |
2007-10-04 |
Rigel Pharmaceuticals, Inc. |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
WO2007070843A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
US20070142287A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Biomed Solutions, Llc |
Compositions And Methods For Treatment Of Cancer
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
WO2007079147A2
(en)
|
2005-12-28 |
2007-07-12 |
Advanced Bionutrition Corporation |
A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
EP2500015A1
(de)
*
|
2006-12-05 |
2012-09-19 |
Landec Corporation |
Verabreichung von Arzneimitteln
|
US20090246155A1
(en)
*
|
2006-12-05 |
2009-10-01 |
Landec Corporation |
Compositions and methods for personal care
|
US20100004124A1
(en)
*
|
2006-12-05 |
2010-01-07 |
David Taft |
Systems and methods for delivery of materials for agriculture and aquaculture
|
US8399007B2
(en)
*
|
2006-12-05 |
2013-03-19 |
Landec Corporation |
Method for formulating a controlled-release pharmaceutical formulation
|
US20090263346A1
(en)
*
|
2006-12-05 |
2009-10-22 |
David Taft |
Systems and methods for delivery of drugs
|
CA2673120C
(en)
|
2006-12-18 |
2012-08-07 |
Advanced Bionutrition Corporation |
A dry food product containing live probiotic
|
US10258571B2
(en)
*
|
2007-02-12 |
2019-04-16 |
Particle Sciences, Inc. |
Delivery devices containing encapsulated and/or practice-bound active pharmaceutical ingredients
|
CA2704111C
(en)
*
|
2007-05-14 |
2017-06-20 |
Sustained Nano Systems Llc |
Hypercompressed particles for controlled release of ophthalmic medications
|
US20090148498A1
(en)
*
|
2007-05-14 |
2009-06-11 |
Sustained Nano Systems Llc |
Controlled release implantable dispensing device and method
|
US8071119B2
(en)
*
|
2007-05-14 |
2011-12-06 |
Sustained Nano Systems Llc |
Controlled release implantable dispensing device and method
|
US8101274B2
(en)
*
|
2007-06-11 |
2012-01-24 |
Spedden Richard H |
Solid state membranes with surface-embedded glycosylated amphiphilic molecules and micelles formed therefrom
|
FR2919188B1
(fr)
*
|
2007-07-27 |
2010-02-26 |
Proteins & Peptides Man |
Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps
|
US8067028B2
(en)
*
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
US8114883B2
(en)
*
|
2007-12-04 |
2012-02-14 |
Landec Corporation |
Polymer formulations for delivery of bioactive materials
|
CA2709712C
(en)
|
2007-12-20 |
2016-05-10 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
JP5681626B2
(ja)
|
2008-07-14 |
2015-03-11 |
ポリーペイド リミテッドPolypid Ltd. |
徐放性薬剤キャリア組成物
|
CA2689472C
(en)
*
|
2008-07-18 |
2019-01-15 |
Karine Theberge |
Articles of manufacture releasing an active ingredient
|
KR20110042107A
(ko)
|
2008-08-07 |
2011-04-22 |
바이오엑티브 써지컬, 아이엔씨. |
의료 장치 및 이식물을 위한 줄기 세포 포획 및 고정화 코팅
|
CN102369105A
(zh)
*
|
2008-09-24 |
2012-03-07 |
莱斯勒斯公司 |
在材料中引入耐热和/或耐压生物
|
WO2010111565A2
(en)
|
2009-03-27 |
2010-09-30 |
Advanced Bionutrition Corporation |
Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
|
EP2435554B1
(de)
|
2009-05-26 |
2017-07-26 |
Advanced Bionutrition Corporation |
Stabile trockenpulverzusammensetzung mit biologisch aktiven mikroorganismen und/oder bioaktiven materialien sowie herstellungsverfahren dafür
|
US8992979B2
(en)
|
2009-07-14 |
2015-03-31 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
JP5860409B2
(ja)
*
|
2010-01-19 |
2016-02-16 |
ポリピッド リミテッド |
徐放性核酸マトリックス組成物
|
WO2011094469A2
(en)
|
2010-01-28 |
2011-08-04 |
Advanced Bionutrition Corporation |
Dry glassy composition comprising a bioactive material
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
JP2013526572A
(ja)
|
2010-05-17 |
2013-06-24 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
眼治療薬の送達のための薬物送達装置
|
NZ607226A
(en)
|
2010-08-13 |
2015-03-27 |
Advanced Bionutrition Corp |
Dry storage stabilizing composition for biological materials
|
JP2013538231A
(ja)
|
2010-09-17 |
2013-10-10 |
ブラッシカ プロテクション プロダクツ リミテッド ライアビリティ カンパニー |
グルコシノレートによる処置のための製剤
|
ITMI20111050A1
(it)
|
2011-06-10 |
2012-12-11 |
Sevecom Spa |
Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali.
|
CN103717206A
(zh)
*
|
2011-07-27 |
2014-04-09 |
波利皮得有限公司 |
用于肽分子和多肽分子的受控释放的基质组合物
|
CN105287431A
(zh)
*
|
2014-05-30 |
2016-02-03 |
中国科学院过程工程研究所 |
一种载活性药物的聚合物脂质球及其制备方法
|
WO2016012881A1
(en)
|
2014-07-21 |
2016-01-28 |
Sevecom S.P.A. |
Powdered emulsion for animal feed
|
AU2015301399B2
(en)
|
2014-08-14 |
2018-11-08 |
Brown University |
Compositions for stabilizing and delivering proteins
|
EP3328215B1
(de)
|
2015-07-29 |
2021-07-07 |
Advanced BioNutrition Corp. |
Stabile trockene probiotische zusammensetzungen für spezielle diätverwendungen
|
US10327935B2
(en)
*
|
2016-07-21 |
2019-06-25 |
Cook Medical Technologies Llc |
Stent graft with internal constraining mechanism
|
CN111989068A
(zh)
|
2018-05-24 |
2020-11-24 |
塞拉尼斯伊娃高性能聚合物公司 |
用于持续释放大分子药物化合物的可植入器件
|
US11690807B2
(en)
|
2018-05-24 |
2023-07-04 |
Celanese Eva Performance Polymers Llc |
Implantable device for sustained release of a macromolecular drug compound
|
CN112094580A
(zh)
*
|
2020-09-01 |
2020-12-18 |
杭州曦茂新材料科技有限公司 |
一种树脂防腐涂料及其生产方法
|
WO2024069235A2
(en)
|
2022-09-30 |
2024-04-04 |
Sixfold Bioscience Ltd. |
Compositions containing oligonucleotides with theranostic applications
|